Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
8/5 23:25
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of -5.26% and 33.94%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...